This compound is primarily utilized in the pharmaceutical industry as an intermediate in the synthesis of various active pharmaceutical ingredients (APIs). Its structure, featuring a chiral center and a methylthio group, makes it valuable for developing enantiomerically pure drugs, such as beta-adrenergic receptor agonists used to treat respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD). While beta-adrenergic receptors are present in the central nervous system, the primary applications of derived drugs focus on peripheral effects for bronchodilation. Additionally, its unique chemical properties make it suitable for research in medicinal chemistry, aiding in the discovery of new therapeutic agents with improved efficacy and reduced side effects.